September 5, 2024
Registration closes on Monday, September 9, for the 2024-2025 cohort of the Minnesota Physician Leadership Institute (MNPLI).
The MNPLI offers an innovative, best-in-class, physician leadership training curriculum to foster professional satisfaction and empower physicians by providing them with the skills, insights, and competencies required to build leadership acumen. The University of Minnesota’s Carlson School of Management is the MMA’s faculty partner for this program.
And now, the program is available for only $5,500.
The 10-month program includes two new sessions for 2024-2025 enrollees:
“Physician Leadership in Quality & Safety” with David Satin, MD. This course will introduce participants to the local, national, and historical quality improvement and patient safety (QI/PS) landscape through small and large group activities.
“Physician Health & Well-being" with Corey Martin, MD, who also serves as a MNPLI program co-chair.
Enrollment is limited to 25, so reserve your spot now. For more information on the program, visit the program website.
The Minnesota Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity has been approved for AMA PRA Category 1 Credit™.
September 11, 2025
A special election to fill the seat left open following the assassination of Speaker Emerita Melissa Hortman is scheduled for September 16. The election for House District 34B includes Brooklyn Park and parts of Coon Rapids.
September 11, 2025
The MMA and five other physician advocacy organizations sent a letter to Gov. Tim Walz, on September 5 urging him to call a special legislative session to “pass legislation to address the devastating death and injuries from firearms and gun violence.”
September 11, 2025
On September 8, Gov. Tim Walz issued an executive order (EO) directing the Minnesota Department of Health (MDH) to expand its efforts to safeguard vaccine access in Minnesota, in response to federal actions restricting vaccine availability.